Natramid/Opumide (Indapamide Hemihydrate)

Indapamide, the active ingredient in Natramid/Opumide, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower high blood pressure and to reduce fluid accumulation in patients with heart‑failure‑related or renal‑disease‑related edema.

GNH USA supplies Natramid/Opumide as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to European quality standards and providing reliable sourcing for hospitals, pharmacies and clinics worldwide. The company manages export logistics, regulatory documentation and post‑market support to ensure uninterrupted patient access through a network of certified partners.

Indapamide is indicated for conditions where reduction of blood pressure or excess fluid is required.

- Hypertension: lowers systolic and diastolic blood pressure, helping to prevent cardiovascular complications. - Edema associated with heart failure: promotes diuresis to decrease fluid overload and improve symptoms. - Edema associated with renal disease: enhances urinary sodium and water excretion to reduce swelling.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Nausea or abdominal discomfort - Increased urinary frequency - Electrolyte disturbances such as low potassium - Photosensitivity or skin rash

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Acute gout attacks - Pancreatitis - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Blood dyscrasias such as agranulocytosis - Hepatic dysfunction

When prescribing indapamide, clinicians should consider several safety measures.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance before initiation. - Evaluate blood pressure: ensure adequate control and avoid excessive hypotension. - Use caution in diabetes: diuretic may affect glucose control. - Avoid in severe hepatic impairment: risk of accumulation. - Store at room temperature: keep in the original container, protect from moisture.

Indapamide can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - Digoxin: enhanced digoxin concentrations can lead to arrhythmias. - Cyclosporine: may raise cyclosporine levels and nephrotoxicity risk.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: diuretic‑induced hypokalemia can enhance insulin sensitivity, requiring dose adjustment. - Other antihypertensives: additive blood‑pressure‑lowering effect may cause hypotension. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce diuretic efficacy and impair renal function. - ACE inhibitors or ARBs: combined use can increase risk of renal impairment and hyperkalemia.